RXST•benzinga•
RxSight Analyst Flags Growth Slowdown As Revised Outlook Misses Expectations
Summary
RxSight revised its FY25 revenue outlook below estimates, with Q1 sales lagging expectations. BofA downgraded the stock, citing slowing growth and risks ahead.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 3, 2025 by benzinga